Core Viewpoint - aTyr Pharma, Inc. is set to report its fourth quarter and full year 2024 financial results on March 13, 2025, and will provide a corporate update during a conference call and webcast [1] Group 1: Financial Reporting - The financial results will be announced after market close on March 13, 2025 [1] - A conference call and webcast will be held at 5:00 p.m. EDT / 2:00 p.m. PDT to review the results [2] Group 2: Company Overview - aTyr Pharma is a clinical stage biotechnology company focused on developing first-in-class medicines from its proprietary tRNA synthetase platform [3] - The company aims to translate tRNA synthetase biology into new therapies for fibrosis and inflammation [3] - The lead therapeutic candidate, efzofitimod, is in clinical development for treating interstitial lung disease, which involves immune-mediated disorders causing lung inflammation and progressive fibrosis [3]
aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2024 Financial Results